The overall Indian pharmaceutical market grown around 12.1 percent by value and 4.8 percent by volume in month of August as per the market research firm AWACS.
Almost all the therapy areas have shown a robust double-digit growth or in case of units the growth may be single digit due to NLEM permission to hike price come into the picture and number of companies have shown a good price driven growth for the month of August.
The market has exhibited both price driven growth and volume driven growth. Gatro, Respiratory, Analgesics, opthalmics, urology segment has shown highest price driven growth. Anti diabetics has a higher NI contribution to growth because of Sitagliptin generics.
Amongst top 20 pharmaceutical companies Cipla, Mankind and Glenmark shows double digit value as well as unit growth.
Antidiabetics segment slipped from top 3 segments where Gastro segment joined top 3 spot with Cardiac and Anti-infectives segment.
